Last updated on March 2018

Adults 18 and older with primary insomnia.


Brief description of study

Adults 18 and older with primary insomnia.

Detailed Study Description

A double-blind randomized, placebo-controlled, 30 night polysomnographic study of an investigational medication in adults 18 and older with primary insomnia.

To qualify, you must be:

  • 18 years and older

Length of study: 6 weeks
Overnight visits: 10
Total number of outpatient visits: 1

For more information,

Clinical Study Identifier: TX134086

Contact Investigators or Research Sites near you

Start Over

Study Coordinator

California Clinical Trials Medical Group, Inc.
Glendale, CA USA
  Connect »